Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Vigil. sanit. debate ; 10(1): 34-39, fev. 2022.
Article in Portuguese | LILACS-Express | LILACS | ID: biblio-1362143

ABSTRACT

Introdução: A pandemia do novo coronavírus teve repercussões no funcionamento dos sistemas de saúde do mundo inteiro. O tabagista foi um grupo diretamente afetado por essas mudanças. Objetivo: Mensurar esse impacto a partir da análise dos dados do Programa Estadual de Controle ao Tabagismo de Pernambuco. Método: Estudo descritivo transversal, utilizando como unidades de análise dados da estratégia de monitoramento do Programa Estadual de Controle ao Tabagismo da Secretaria Estadual de Saúde de Pernambuco (SES-PE), comparando os atendimentos no segundo quadrimestre dos anos de 2019 e 2020. Resultados: Entre maio e agosto de 2019, 3.282 pacientes tabagistas buscaram tratamento para cessação do tabagismo no SUS, em Pernambuco. Em período similar, entre os meses de maio e agosto do ano de 2020, o tratamento para cessação do tabagismo foi procurado por 680 usuários tabagistas, representando uma queda de 79,28%. Além disso, o número de municípios oferecendo tratamento para cessação do tabagismo no SUS caiu de 97 para 36 (62,89%) e o número de unidades de saúde da atenção básica realizando tratamento para cessação do tabagismo no SUS de 277 para 80 (71,11%). Conclusões: A diminuição da oferta do tratamento pelo Programa Estadual de Combate ao Tabagismo é preocupante. Ainda que a sua relação com a COVID-19 não esteja completamente elucidada, a cessação do uso do tabaco traz benefícios já bem estabelecidos. Dessa forma, é necessário incentivar a adoção de novas estratégias e tecnologias, aproveitando a janela de oportunidade que o temor da associação COVID-19/tabagismo criou.


Introduction: The new Coronavirus pandemic has had an impact on health systems worldwide. Smokers were directly affected by these changes. Objective: To measure the new Coronavirus pandemic impact on smoking cessation from the analysis of data from the Pernambuco State Tobacco Control Program. Method: Descriptive cross-sectional study, using data from the monitoring strategy of the State Tobacco Control Program of the State Health Secretariat of Pernambuco (SES-PE) as the unit of analysis, comparing services in the second quarter of 2019 and 2020. Results: Between May and August 2019, 3.282 smoking patients sought treatment for smoking cessation in SUS, in Pernambuco. In a similar period, between the months of May and August of the year 2020, treatment for smoking cessation was sought by 680 smoking users, representing a drop of 79,28%. In addition, the number of municipalities offering treatment for smoking cessation in SUS dropped from 97 to 36 (62,89%) and the number of primary health care units providing treatment for smoking cessation in SUS went from 277 to 80 (71,11%). Conclusions: The decrease in the offer of treatment by the State Program to Combat Smoking is worrying. Although its relation with COVID-19 has not been fully elucidated, the cessation of tobacco use has already established benefts. Thus, it is necessary to encourage the adoption of new strategies and technologies, using the window of opportunity that the fear of COVID-19/smoking association created.

2.
Rev. bras. cir. cardiovasc ; 32(3): 225-227, May-June 2017. tab, graf
Article in English | LILACS | ID: biblio-897916

ABSTRACT

Abstract Melanoma is a tumor that virtually involves any tissue and commonly metastasizes to the heart. It is usually not diagnosed because of the absent/nonspecific cardiac signs and symptoms. Herein, we present a case of a 41-year-old man without any cardiovascular risk factor, admitted to the emergency room with chest pain, diagnosed with a myocardial infarction. Due to the presence of a mass adjacent to the mitral valve on the cardiac ultrasound examination, causing mitral regurgitation, the patient was referred to surgery. Pathological analysis of the excised specimens diagnosed the melanoma. The chemotherapy was started and achieved a partial response. Cardiac metastases usually affect the myocardium, leaving the valves unaffected. In this case, the acute coronary syndrome was the first manifestation of the malignant melanoma. We highlight the high level of suspicion needed in these cases.


Subject(s)
Humans , Male , Adult , Acute Coronary Syndrome/pathology , Heart Neoplasms/pathology , Heart Neoplasms/secondary , Melanoma/pathology , Melanoma/secondary , Immunohistochemistry , Echocardiography , Treatment Outcome , Diagnosis, Differential , Acute Coronary Syndrome/diagnostic imaging , Heart Neoplasms/surgery , Heart Neoplasms/diagnostic imaging , Melanoma/surgery , Melanoma/diagnostic imaging , Mitral Valve/surgery , Mitral Valve/pathology
SELECTION OF CITATIONS
SEARCH DETAIL